Cambridge Investment Research Advisors, Inc.
Position in IBRX — ImmunityBio, Inc.
CIK 1419186
FAIRFIELD, IA
Position in IBRX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$2,183,679
+$1,608,337 QoQ
Shares Held
284,704
-2.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
14 quarters on record
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $50,208,596 across 75 Biotechnology names. IBRX ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,955 | $7,124,545 | |
| 2 | EXEL |
Exelixis, Inc.
|
159,749 | $6,851,634 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,055 | $4,033,157 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,832 | $3,733,396 | |
| 5 | IBRX |
ImmunityBio, Inc.
This page
|
284,704 | $2,183,679 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
29,059 | $2,157,921 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
37,992 | $1,807,279 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
42,754 | $1,723,413 |
All Filings in IBRX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,183,679 | 284,704 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $575,342 | 290,577 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $172,913 | 70,290 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $55,308 | 20,950 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $54,029 | 17,950 | Shares | Sole | 2025-04-22 | |
| 2024-09-30 | $54,010 | 14,519 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $87,336 | 13,819 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $77,596 | 14,450 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $75,049 | 14,950 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $25,265 | 14,950 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $41,561 | 14,950 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $25,389 | 13,950 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $60,586 | 11,950 | Shares | Sole | 2023-02-08 | |
| 2021-06-30 | $407,951 | 28,568 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||